InsidersTradesSigma
Browse the complete record of transactions filed by Scangos George A, Director General. Insider active across 2 companies, notably Vir Biotechnology, Inc.. Aggregated, 3 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €281k. History available since 17 February 2022. The latest transaction was filed on 10 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 de 3 declaraciones
George A. Scangos is the President and CEO of Vir Biotechnology, Inc. and Agilent Technologies, Inc. He leads corporate strategies and growth initiatives, focusing on innovation in the biotechnology sector. His experience is a significant asset to both companies.